Current Neuropharmacology
Title:ERRATUM
Volume: 10 Issue: 2
Export Options
About this article
Cite this article as:
ERRATUM, Current Neuropharmacology 2012; 10 (2) . https://dx.doi.org/10.2174/157015912800604506
DOI https://dx.doi.org/10.2174/157015912800604506 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
34
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association between Hypocretin-1 and Amyloid-β42 Cerebrospinal Fluid Levels in Alzheimer’s Disease and Healthy Controls
Current Alzheimer Research The Role of Blood-Brain Barrier Studies in the Pharmaceutical Industry
Current Drug Metabolism Achieving Detumescence of Ischemic Priapism with Intra-Cavernosal Injection of entanyl: An Unexpected Outcome of Miscommunication Error
Current Drug Safety Optimization of Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design Role of Cardiolipin in Mitochondrial Diseases and Apoptosis
Current Medicinal Chemistry Histamine H3 Receptor Ligands in the Group of (Homo)piperazine Derivatives
Current Medicinal Chemistry New Approaches to Develop Drug Treatment for Alzheimer’s Disease: Targeting Calcium Dysregulation
Current Alzheimer Research Introduction to Metabolic Genetic Engineering for the Production of Valuable Secondary Metabolites in in vivo and in vitro Plant Systems
Recent Patents on Biotechnology Emerging Opportunities and Concerns for Drug Discovery at Serotonin 5-5-HT2B Receptors
Current Topics in Medicinal Chemistry Application of Proteomics to the Discovery of Cancer Biomarkers
Current Cancer Therapy Reviews Genetic Interactions Effects of Cardiovascular Disorder Using Computational Models: A Review
Current Biotechnology Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment
Current Pharmaceutical Design Internal Jugular Vein Valve Morphology in the Patients with Chronic Cerebrospinal Venous Insufficiency (CCSVI); Angiographic Findings and Schematic Demonstrations
Reviews on Recent Clinical Trials A New Interpretative Paradigm for Conformational Protein Diseases
Current Protein & Peptide Science From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Pharmacotherapy for Smoking Cessation: Present and Future
Current Pharmaceutical Design Polyamine Modulation of NMDARs as a Mechanism to Reduce Effects of Alcohol Dependence
Recent Patents on CNS Drug Discovery (Discontinued) Targeted D4 Dopamine Receptors: Implications for Drug Discovery and Therapeutic Development
Current Drug Targets Editorial [Hot Topic: Perspectives in Integrin Blocking (Executive Editor: C. Marcinkiewicz)]
Current Pharmaceutical Design Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
Current Cancer Drug Targets